The FDA greenlit multiple new drugs this month and issued some notable label expansions, including for Eli Lilly’s Kisunla.

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

Data are Consistent with Phase 2 Double-Blind Trial and Support Advancement of ATH434 in MSA – MELBOURNE, Australia and SAN FRANCISCO, (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ...

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results SOUTH SAN FRANSCISCO, Calif., Jul ...

That's why we've created this year's ultimate cheat sheet, the second edition of Esquire Essentials. We've eliminated the ...

The SGX945 proof of concept pilot study was an open-label study that enrolled 8 patients age 18 years or older with mild to ...

In our weekly column, Future Food Quick Bites, we round up the latest developments in the alt-protein and sustainable food ...

U.S. stock futures rose on Wednesday after ending lower on Tuesday. Futures of major benchmark indices were slightly higher.

With the help of the best tools, it's never been easier (or more fun!) to be a DIYer. Here are 45 of our top picks, tested by editors. Stocking a toolbox isn’t something that happens in a day. When it ...